$TRVX #Targovax AS Targovax - Confirmatory 12-month mesothelioma update: On 22 June 2020 Targovax reported data from its Phase I/II study in unresectable mesothelioma (a follow up to the first data published in January 2020). There were… https://t.co/b6libThVVT #equity #stocks https://t.co/quMNe51UCu